Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 860602, 21 pages
http://dx.doi.org/10.1155/2013/860602
Review Article

Differentiated Evaluation of Extract-Specific Evidence on Cimicifuga racemosa's Efficacy and Safety for Climacteric Complaints

1Department of Naturopathy, Blankenstein Hospital, Im Vogelsang 5-11, 45527 Hattingen, Germany
2Department of Gynecology, Lübbecke Hospital, Virchowstraße 65, 32312 Lübbecke, Germany

Received 13 May 2013; Accepted 21 June 2013

Academic Editor: Brent Bauer

Copyright © 2013 A.-M. Beer and A. Neff. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V. Hormontherapie in der Peri- und Postmenopause (HT). Interdisziplinäre S3-Leitlinie. Stand, 2009.
  2. U. Schwabe and D. Paffrath, Eds., Arzneiverordnungs-Report 2008, Springer, Heidelberg, Germany, 2008.
  3. C. Scheidt-Nave and M. Dören, “Editorial,” in Hormontherapie bei (post-) menopausalen Frauen in Deutschland 2007. Studienergebnisse zu Nutzen, Risiken und Versorgungsrealität, Robert Koch-Institut, Ed., vol. 2008, pp. 5–12, Berlin, Germany.
  4. G. L. Anderson, M. Limacher, A. R. Assaf et al., “Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial,” The Journal of the American Medical Association, vol. 291, no. 14, pp. 1701–1712, 2004. View at Publisher · View at Google Scholar
  5. J. E. Rossouw, G. L. Anderson, R. L. Prentice et al., “Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial,” Journal of the American Medical Association, vol. 288, no. 3, pp. 321–333, 2002. View at Google Scholar · View at Scopus
  6. G. P. Cumming, J. Herald, R. Moncur, H. Currie, and A. J. Lee, “Women's attitudes to hormone replacement therapy, alternative therapy and sexual health: a web-based survey,” Menopause International, vol. 13, no. 2, pp. 79–83, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A.-M. Beer and B. Nobis, “Gynäkologische Erkrankungen und Geburtshilfe,” in Leitfaden Naturheilverfahren für die ärztliche Praxis, A.-M. Beer and M. Adler, Eds., pp. 521–556, Elsevier, Urban & Fischer, München, Germany, 2011. View at Google Scholar
  8. EMA European Medicine Agency. Committee on Herbal Medicinal Products (HMPC). Community herbal monograph on Cimicifuga racemosa (L.) Nutt., rhizome. EMA/HMPC/600717/2007 Corr., 2011.
  9. ESCOP Monographs. CIMICIFUGAE RHIZOMABlack Cohosh. European Scientific Cooperative on Phytotherapy, Exeter, UK, 2011, http://www.escop.com/.
  10. E. J. Kennelly, S. Baggett, P. Nuntanakorn et al., “Analysis of thirteen populations of black cohosh for formononetin,” Phytomedicine, vol. 9, no. 5, pp. 461–467, 2002. View at Google Scholar · View at Scopus
  11. B. Avula, Y. H. Wang, T. J. Smillie, and I. A. Khan, “Quantitative determination of triterpenoids and formononetin in rhizomes of black cohosh (Actaea racemosa) and dietary supplements by using UPLC-UV/ELS detection and identification by UPLC-MS,” Planta Medica, vol. 75, no. 4, pp. 381–386, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. J. Leach and V. Moore, “Black cohosh, (Cimicifuga spp.) for menopausal symptoms,” Cochrane Database of Systematic Reviews, vol. 9, Article ID CD007244, 2012. View at Publisher · View at Google Scholar
  13. C. Palacio, G. Masri, and A. D. Mooradian, “Black cohosh for the management of menopausal symptoms: a systematic review of clinical trials,” Drugs and Aging, vol. 26, no. 1, pp. 23–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Borrelli and E. Ernst, “Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy,” Pharmacological Research, vol. 58, no. 1, pp. 8–14, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A.-M. Beer, “Herbal medicines used in kidney diseases in Europe,” Iranian Journal of Kidney Diseases, vol. 5, no. 2, pp. 82–85, 2011. View at Google Scholar · View at Scopus
  16. F. Gaedcke and A.-M. Beer, “Pflanzliche Arzneimittel versus pflanzliche Nahrungsergänzungsmittel. Der Unterschied liegt in der Qualität,” MMW: Fortschritte der Medizin, vol. 152, no. 16, pp. 36–38, 2010. View at Google Scholar
  17. Oxford Centre for Evidence-based Medicine Levels of Evidence (March 2009), http://www.cebm.net/index.aspx?o=4590.
  18. R. Osmers, M. Friede, E. Liske, J. Schnitker, J. Freudenstein, and H.-H. Henneicke-von Zepelin, “Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms,” Obstetrics and Gynecology, vol. 105, pp. 1074–1083, 2005. View at Google Scholar · View at Scopus
  19. E. Liske, W. Hänggi, H.-H. Henneicke-von Zepelin et al., “Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect,” Journal of Women's Health and Gender-Based Medicine, vol. 11, no. 2, pp. 163–174, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Bai, H.-H. Henneicke-von Zepelin, S. Wang et al., “Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone,” Maturitas, vol. 58, no. 1, pp. 31–41, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. R. E. Nappi, B. Malavasi, B. Brundu, and F. Facchinetti, “Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol,” Gynecological Endocrinology, vol. 20, no. 1, pp. 30–35, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Vermes, F. Banhidy, and N. Acs, “The effects of Remifemin on subjective symptoms of menopause,” Advances in Therapy, vol. 22, no. 2, pp. 148–154, 2005. View at Publisher · View at Google Scholar
  23. M. Schmidt, W. Polasek, and R. Käufeler, “Wirksamkeit und Sicherheit von Traubensilberkerze (Cimicifuga racemosa, Cimifemin) bei Menopausebeschwerden: Therapiebeobachtung unter Praxisbedingungen,” Journal für Menopause, vol. 12, no. 1, pp. 30–34, 2005. View at Google Scholar
  24. M. D. Julia Molla, Y. Garcia-Sanchez, A. R. Sarrio, and F. R. Perez-Lopez, “Cimicifuga racemosa treatment and health related quality of life in post-menopausal Spanish women,” Gynecological Endocrinology, vol. 25, no. 1, pp. 21–26, 2009. View at Publisher · View at Google Scholar
  25. V. Briese, U. Stammwitz, M. Friede, and H. H. Henneicke-von Zepelin, “Black cohosh with or without St. John's wort for symptom-specific climacteric treatment—results of a large-scale, controlled, observational study,” Maturitas, vol. 57, no. 4, pp. 405–414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Uebelhack, J. U. Blohmer, H. J. Graubaum, R. Busch, J. Gruenwald, and K. D. Wernecke, “Black cohosh and St. John's wort for climacteric complaints: a randomized trial,” Obstetrics and Gynecology, vol. 107, no. 2, pp. 247–255, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. J. Chung, H. Y. Kim, K. H. Park et al., “Black cohosh and St. John's wort (GYNO-Plus) for climacteric symptoms,” Yonsei Medical Journal, vol. 48, no. 2, pp. 289–294, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Wuttke, D. Seidlová-Wuttke, and C. Gorkow, “The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers,” Maturitas, vol. 44, supplement 1, pp. S67–S77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Wuttke, K. Rauš, and C. Gorkow, “Efficacy and tolerability of the Black cohosh (Actaea racemosa) ethanolic extract BNO 1055 on climacteric complaints: a double-blind, placebo- and conjugated estrogens-controlled study,” Maturitas, vol. 55, no. 1, pp. S83–S91, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Rauš, C. Brucker, C. Gorkow, and W. Wuttke, “First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055,” Menopause, vol. 13, no. 4, pp. 678–691, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. W. D. Kaiser, R. Martin, R. Schellenberg, E. Schrader, and R. Saller, “Cimicifuga-racemosa-Extrakt Ze 450 bei Wechseljahrbeschwerden,” Ars Medici, vol. 17, pp. 771–774, 2008. View at Google Scholar
  32. S. Frei-Kleiner, W. Schaffner, V. W. Rahlfs, C. Bodmer, and M. Birkhäuser, “Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial,” Maturitas, vol. 51, no. 4, pp. 397–404, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Oktem, D. Eroglu, H. B. Karahan, N. Taskintuna, E. Kuscu, and H. B. Zeyneloglu, “Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial,” Advances in Therapy, vol. 24, no. 2, pp. 448–461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. R. L. Ruhlen, J. Haubner, J. K. Tracy et al., “Black cohosh does not exert an estrogenic effect on the breast,” Nutrition and Cancer, vol. 59, no. 2, pp. 269–277, 2007. View at Google Scholar · View at Scopus
  35. K. M. Newton, S. D. Reed, A. Z. LaCroix, L. C. Grothaus, K. Ehrlich, and J. Guiltinan, “Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial,” Annals of Internal Medicine, vol. 145, no. 12, pp. 869–879, 2006. View at Google Scholar · View at Scopus
  36. S. E. Geller, L. P. Shulman, R. B. van Breemen et al., “Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial,” Menopause, vol. 16, no. 6, pp. 1156–1166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Naser, J. Schnitker, M. J. Minkin, S. Garcia de Arriba, K. U. Nolte, and R. Osmers, “Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract,” Menopause, vol. 18, no. 4, pp. 366–375, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Lundström, A. L. Hirschberg, and G. Söderqvist, “Digitized assessment of mammographic breast density. Effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo,” Maturitas, vol. 70, no. 4, pp. 361–364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. J. S. Jacobson, A. B. Troxel, J. Evans et al., “Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer,” Journal of Clinical Oncology, vol. 19, no. 10, pp. 2739–2745, 2001. View at Google Scholar · View at Scopus
  40. M. A. García-Pérez, B. Pineda, C. Hermenegildo, J. J. Tarín, and A. Cano, “Isopropanolic Cimicifuga racemosa is favorable on bone markers but neutral on an osteoblastic cell line,” Fertility and Sterility, vol. 91, no. 4, supplement, pp. 1347–1350, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Rostock, J. Fischer, A. Mumm, U. Stammwitz, R. Saller, and H. H. Bartsch, “Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints—a prospective observational study,” Gynecological Endocrinology, vol. 27, no. 10, pp. 844–848, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. N. E. Reame, J. L. Lukacs, V. Padmanabhan, A. D. Eyvazzadeh, Y. R. Smith, and J. K. Zubieta, “Black cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging,” Menopause, vol. 15, no. 5, pp. 832–840, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Lindén-Hirschberg, M. Edlund, G. Svane, E. Azavedo, L. Skoog, and B. von Schoultz, “An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women,” Menopause, vol. 14, no. 1, pp. 89–96, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. B. A. Pockaj, C. L. Loprinzi, J. A. Sloan et al., “Pilot evaluation of black cohosh for the treatment of hot flashes in women,” Cancer Investigation, vol. 22, no. 4, pp. 515–521, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Obi, J. Chang-Claude, J. Berger et al., “The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a German case-control study,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 8, pp. 2207–2213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. T. R. Rebbeck, A. B. Troxel, S. Norman et al., “A retrospective case-control study of the use of hormone-related supplements and association with breast cancer,” International Journal of Cancer, vol. 120, no. 7, pp. 1523–1528, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. H. H. Henneicke-von Zepelin, H. Meden, K. Kostev, D. Schröder-Bernhardi, U. Stammwitz, and H. Becher, “Isopropanolic black cohosh extract and recurrence-free survival after breast cancer,” International Journal of Clinical Pharmacology and Therapeutics, vol. 45, no. 3, pp. 143–154, 2007. View at Google Scholar · View at Scopus
  48. W. Wuttke, C. Gorkow, and D. Seidlová-Wuttke, “Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study,” Menopause, vol. 13, no. 2, pp. 185–196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Hernández Muñoz and S. Pluchino, “Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer,” Maturitas, vol. 44, supplement 1, pp. S59–S65, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Nasr and H. Nafeh, “Influence of black cohosh (Cimicifuga racemosa) use by postmenopausal women on total hepatic perfusion and liver functions,” Fertility and Sterility, vol. 92, no. 5, pp. 1780–1782, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Spangler, K. M. Newton, L. C. Grothaus, S. D. Reed, K. Ehrlich, and A. Z. LaCroix, “The effects of black cohosh therapies on lipids, fibrinogen, glucose and insulin,” Maturitas, vol. 57, no. 2, pp. 195–204, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. S. D. Reed, K. M. Newton, A. Z. LaCroix, L. C. Grothaus, V. S. Grieco, and K. Ehrlich, “Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study,” Menopause, vol. 15, no. 1, pp. 51–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. B. M. Johnson and R. B. van Breemen, “In vitro formation of quinoid metabolites of the dietary supplement Cimicifuga racemosa (black cohosh),” Chemical Research in Toxicology, vol. 16, no. 7, pp. 838–846, 2003. View at Google Scholar · View at Scopus
  54. R. B. van Breemen, W. Liang, S. Banuvar et al., “Pharmacokinetics of 23-epi-26-deoxyactein in women after oral administration of a standardized extract of black cohosh,” Clinical Pharmacology and Therapeutics, vol. 87, no. 2, pp. 219–225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. B. J. Gurley, S. F. Gardner, M. A. Hubbard et al., “In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes,” Clinical Pharmacology and Therapeutics, vol. 77, no. 5, pp. 415–426, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. B. J. Gurley, G. W. Barone, D. K. Williams et al., “Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans,” Drug Metabolism and Disposition, vol. 34, no. 1, pp. 69–74, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. J. D. Amsterdam, Y. Yao, J. J. Mao, I. Soeller, K. Rockwell, and J. Shults, “Randomized, double-blind, placebo-controlled trial of Cimicifuga racemosa (black cohosh) in women with anxiety disorder due to menopause,” Journal of Clinical Psychopharmacology, vol. 29, no. 5, pp. 478–483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. F. Firenzuoli, L. Gori, and P. Roberti di Sarsina, “Black cohosh hepatic safety: follow-up of 107 patients consuming a special Cimicifuga racemosa rhizome herbal extract and review of literature,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 821392, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. T. M. Brasky, J. W. Lampe, J. D. Potter, R. E. Patterson, and E. White, “Specialty supplements and breast cancer risk in the VITamins and Lifestyle (VITAL) cohort,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 7, pp. 1696–1708, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. A.-M. Beer, “Cimicifuga racemosa (Traubensilberkerze, Wanzenkraut),” in Naturheilverfahren und unkonventionelle medizinische Richtungen, M. Bühring and F. H. Kemper, Eds., 08.19, Springer Loseblatt Systeme, 1997. View at Google Scholar
  61. Commission E of the German Health Authority. Monograph Cimicifugae racemosae rhizoma. BAnz, 43, 1070, 1989.
  62. G. A. Hauser, “Häufigkeit klimakterischer Symptome—eine Literaturübersicht,” in Menopause, Hormonsubstitution heute, C. Lauritzen, Ed., Band 5, pp. 18–21, Stabil Verlag GmbH, München, Germany, 1992. View at Google Scholar
  63. F. A. Leidenberger, Klinische Endokrinologie für Frauenärzte, 134, Springer, Berlin, Germany, 1998.
  64. B. Jiang, F. Kronenberg, P. Nuntanakorn, M.-H. Qiu, and E. J. Kennelly, “Evaluation of the botanical authenticity and phytochemical profile of black cohosh products by high-performance liquid chromatography with selected ion monitoring liquid chromatography-mass spectrometry,” Journal of Agricultural and Food Chemistry, vol. 54, no. 9, pp. 3242–3253, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. European Medicine Agency. Committee on Herbal Medicinal Products (HMPC). Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (Black cohosh, root). Doc Ref: EMEA/HMPC/269258/2006 Rev. 1., 2007.
  66. R. Teschke and A. Schwarzenboeck, “Suspected hepatotoxicity by Cimicifugae racemosae rhizoma (black cohosh, root): critical analysis and structured causality assessment,” Phytomedicine, vol. 16, no. 1, pp. 72–84, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. G. B. Mahady, T. Low Dog, M. L. Barrett et al., “United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity,” Menopause, vol. 15, no. 4, part 1, pp. 628–638, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Teschke, “Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review,” Menopause, vol. 17, no. 2, pp. 426–440, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. R. Teschke, R. Bahre, A. Genthner, J. Fuchs, W. Schmidt-Taenzer, and A. Wolff, “Suspected black cohosh hepatotoxicity—challenges and pitfalls of causality assessment,” Maturitas, vol. 63, no. 4, pp. 302–314, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. R. Teschke, R. Bahre, J. Fuchs, and A. Wolff, “Black cohosh hepatotoxicity: quantitative causality evaluation in nine suspected cases,” Menopause, vol. 16, no. 5, pp. 956–965, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. R. Teschke, A. Schwarzenboeck, W. Schmidt-Taenzer, A. Wolff, and K.-H. Hennermann, “Herb induced liver injury presumably caused by black cohosh: a survey of initially purported cases and herbal quality specifications,” Annals of Hepatology, vol. 10, no. 3, pp. 249–259, 2011. View at Google Scholar · View at Scopus
  72. R. Teschke, W. Schmidt-Taenzer, and A. Wolff, “Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?” Pharmacoepidemiology and Drug Safety, vol. 20, no. 6, pp. 567–582, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. R. Teschke and J. Schulze, “Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia,” Drug Safety, vol. 35, no. 12, pp. 1091–1097, 2012. View at Google Scholar